The two fractions were then offered to the C3.g7 APC line (B-cell lymphoma expressing I-Ag7) for antigen presentation to 6.9HIP-reactive, I-Ag7-restricted CD4 T-cell hybridomas. This evidence concerns the gene CD4 and B-cell non-Hodgkin lymphoma.